Enjoy complimentary customisation on priority with our Enterprise License!
The peptide therapeutics market share is expected to increase to USD 23.36 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 12.52%.
This peptide therapeutics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers peptide therapeutics market segmentation by route of administration (parenteral, oral, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The peptide therapeutics market report also offers information on several market vendors, including Almac Group Ltd., AmbioPharm Inc., Amgen Inc., AstraZeneca Plc, Bachem AG, Bristol Myers Squibb Co., Corden Pharma International GmbH, Eli Lilly and Co., Ever Pharma, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Ipsen Pharma, Lonza Group Ltd., Novartis AG, Novo Nordisk AS, PeptiDream Inc., Pfizer Inc., PolyPeptide Group, Sanofi, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Worg pharma among others.
Download the Free Report Sample to Unlock the Peptide Therapeutics Market Size for the Forecast Period and Other Important Statistics
The increasing prevalence of infectious diseases is notably driving the peptide therapeutics market growth, although factors such as complexities in manufacturing, storage conditions, distribution policies, and high cost may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the peptide therapeutics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Peptide Therapeutics Market Driver
One of the key factors driving the global peptide therapeutics industry growth is the increasing prevalence of infectious diseases. The outbreak of infectious disease has increased due to changing lifestyles, which result in reduced immunity. The pattern of infection incidence has also been changing with the evolution of drug-resistant pathogens. HIV/AIDS is a leading cause of death in many countries, however, it has decreased in many countries since 2010. For instance, the prevalence of meningococcal disease, which is caused by the bacterium Neisseria, meningitides, was decreased, owing to the meningococcal vaccines, which were licensed and made available in August 2020 in the US. According to the CDC data, of 2021, annually, almost 4,100 cases and 500 deaths occur due to meningococcal disease in the US. Thus, a rise in the incidence and prevalence of infectious diseases due to climate change is expected to drive market growth during the forecast period.
Key Peptide Therapeutics Market Trend
Collaboration for research and development is one of the key peptide therapeutics market trends that is expected to impact the industry positively in the forecast period. Companies are entering into strategic alliances to overcome technological and research challenges. For instance, AstraZeneca entered into a collaboration agreement with Bicycle Therapeutics for the development of novel peptide-based therapies using Bicycles, which is Bicycle Therapeutics novel peptide technology for the treatment of respiratory, cardiovascular, and various metabolic disorders. AstraZeneca agreed to pay USD 1 billion to Bicycle Therapeutics. The pharmaceutical companies such as Novo Nordisk, Zealand Pharma, and Zydus Cadila sponsor various research programs with the Peptide Therapeutics Foundation, a not-for-profit organization focusing on the development of peptides for the treatment of various indications, which will further support the market growth in the coming years.
Key Peptide Therapeutics Market Challenge
One of the key challenges to the global peptide therapeutics industry growth is the complexities in manufacturing, storage conditions, distribution policies, and high cost. The manufacturing process of proteins is very complex and time-consuming, as it involves fermentation, clarification, separation, and purification. The purification process is lengthy, and the risk of contamination is high as the drug is produced in a biological medium. All through the process, proper temperature, pressure, and pH should be maintained. For instance, Eprex, a biosimilar, was found to be structurally unidentical to Amgen EPOGEN as small differences were found in the hydrodynamic structure and the degree of alfa helicity, which affected the stability of the product. In addition, these processes require large investments in biotechnology and sterile production facilities. Insulin treatment also suffers from poor storage and distribution policies. Inadequate distribution policies and lack of a centralized supply chain lead to intra-country variability in pricing. Such factors may impede the market growth in the forecast period.
This peptide therapeutics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global peptide therapeutics market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the peptide therapeutics market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the peptide therapeutics market encompasses successful business strategies deployed by the key vendors. The peptide therapeutics market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The peptide therapeutics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the peptide therapeutics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
39% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for peptide therapeutics in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).
The significant increase in the sales of peptide therapeutics and the rising number of biosimilars will facilitate the peptide therapeutics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The COVID-19 pandemic spread widely across North America, especially in the US, in 2020. However, in Q1 2021, the initiation of vaccination programs led to the resumption of business operations, including the supply chain of peptide therapeutics. The regional peptide therapeutics market witnessed positive growth in 2021 due to the increase in the demand for peptide therapeutics to mitigate the threat of COVID-19. Due to this, the regional peptide therapeutics market will grow during the forecast period
To gain further insights on the market contribution of various segments Request for a FREE sample
The peptide therapeutics market share growth by the parenteral segment will be significant during the forecast period. Most of the major peptide drugs that are currently approved in the market are administered through the parenteral route. The popularity of parenteral RoA for peptide therapeutics is largely due to the rapid absorption of drugs and, thereby, the avoidance of drug loss through first-pass metabolism. Such factors will drive the segment growth in the coming years.
This report provides an accurate prediction of the contribution of all the segments to the growth of the peptide therapeutics market size and actionable market insights on post COVID-19 impact on each segment.
|
Peptide Therapeutics Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 12.52% |
|
Market growth 2022-2026 |
$ 23.36 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
8.8 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 39% |
|
Key consumer countries |
US, Canada, Germany, UK, and China |
|
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
|
Key companies profiled |
Almac Group Ltd., AmbioPharm Inc., Amgen Inc., AstraZeneca Plc, Bachem AG, Bristol Myers Squibb Co., Corden Pharma International GmbH, Eli Lilly and Co., Ever Pharma, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Ipsen Pharma, Lonza Group Ltd., Novartis AG, Novo Nordisk AS, PeptiDream Inc., Pfizer Inc., PolyPeptide Group, Sanofi, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Worg pharma |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Route of Administration
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
